Clinical trial

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression

NCT03749629

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-05-01

PhaseNA

Study timeline

Study start (actual)2019-05-01Date precision: day

Registry last updated2022-04-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

GeneSight Psychotropic testOTHER

Canadian Network for Mood and Anxiety Treatment (CANMAT) Best Practice GuidelinesOTHER

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

Genetic Alliancecollaborator

Patient-Centered Outcomes Research Institutecollaborator

Vanderbilt Universitycollaborator

Montefiore Medical Centercollaborator

Louisiana State University Health Sciences Center in New Orleanscollaborator

Duke Universitycollaborator

University of North Carolina, Chapel Hillcollaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03749629 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.